Slingerlands, NY, United States of America

Sally Temple

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Slingerlands, NY (US) (2011 - 2018)
  • Rensselaer, NY (US) (2021 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sally Temple

Introduction

Sally Temple is a prominent inventor based in Slingerlands, NY (US), known for her significant contributions to the field of biotechnology. With a total of five patents to her name, she has made remarkable strides in the development of therapeutic solutions for neurodegenerative diseases.

Latest Patents

Among her latest patents are the bi-functional anti-tau polypeptides, which are designed to target tauopathies. These multifunctional polypeptides consist of a first domain that includes an anti-tau antigen binding domain and a second domain featuring a proteasome-targeting PEST motif. The innovative methods for utilizing these polypeptides in the treatment of tauopathies highlight her commitment to advancing medical science.

Career Highlights

Sally Temple has worked with notable organizations such as the Regenerative Research Foundation and Albany Medical College. Her work in these institutions has allowed her to collaborate with leading experts in the field, further enhancing her research and development efforts.

Collaborations

Some of her notable coworkers include Anne Messer and David Butler, who have contributed to her projects and research initiatives.

Conclusion

Sally Temple's innovative work and dedication to addressing complex medical challenges through her patents exemplify her role as a leading inventor in biotechnology. Her contributions continue to pave the way for advancements in the treatment of neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…